Cargando…
Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection
Beyond its widely recognized morbidity and mortality, coronavirus disease 2019 poses an additional health risk to renal allograft recipients. Detection and measurement of donor-derived cell-free DNA (dd-cfDNA), expressed as a fraction of the total cell-free DNA (cfDNA), has emerged as a noninvasive...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078311/ https://www.ncbi.nlm.nih.gov/pubmed/33912658 http://dx.doi.org/10.1097/TXD.0000000000001145 |
_version_ | 1783685033369796608 |
---|---|
author | Bunnapradist, Suphamai Datta, Nakul Schaenman, Joanna Ioannou, Nick Bloom, Michelle S. Malhotra, Meenakshi Tabriziani, Hossein Gauthier, Philippe Ahmed, Ebad Billings, Paul R. Lum, Erik L. |
author_facet | Bunnapradist, Suphamai Datta, Nakul Schaenman, Joanna Ioannou, Nick Bloom, Michelle S. Malhotra, Meenakshi Tabriziani, Hossein Gauthier, Philippe Ahmed, Ebad Billings, Paul R. Lum, Erik L. |
author_sort | Bunnapradist, Suphamai |
collection | PubMed |
description | Beyond its widely recognized morbidity and mortality, coronavirus disease 2019 poses an additional health risk to renal allograft recipients. Detection and measurement of donor-derived cell-free DNA (dd-cfDNA), expressed as a fraction of the total cell-free DNA (cfDNA), has emerged as a noninvasive biomarker for allograft rejection. Here, we present a case report of a patient who was infected with severe acute respiratory syndrome coronavirus 2, 11 mo post–kidney transplant. The patient was serially monitored using an analytically and clinically validated massively multiplex PCR-based dd-cfDNA assay to assess allograft injury and risk for rejection. Over the course of infection, low dd-cfDNA fractions were observed (below the 1% cutoff) and were accompanied by unusually highly elevated levels of total cfDNA, which gradually declined as the infection resolved. The case study highlights the variability in total cfDNA levels during and after viral infection, and the need to consider both total and dd-cfDNA levels when clinically interpreting the results for allograft rejection. Furthermore, the study highlights the importance of serial testing, wherein an interplay between total cfDNA and dd-cfDNA can inform the optimization of a patient’s immunosuppressive treatment regimen in response to infection. |
format | Online Article Text |
id | pubmed-8078311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-80783112021-04-27 Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection Bunnapradist, Suphamai Datta, Nakul Schaenman, Joanna Ioannou, Nick Bloom, Michelle S. Malhotra, Meenakshi Tabriziani, Hossein Gauthier, Philippe Ahmed, Ebad Billings, Paul R. Lum, Erik L. Transplant Direct Kidney Transplantation Beyond its widely recognized morbidity and mortality, coronavirus disease 2019 poses an additional health risk to renal allograft recipients. Detection and measurement of donor-derived cell-free DNA (dd-cfDNA), expressed as a fraction of the total cell-free DNA (cfDNA), has emerged as a noninvasive biomarker for allograft rejection. Here, we present a case report of a patient who was infected with severe acute respiratory syndrome coronavirus 2, 11 mo post–kidney transplant. The patient was serially monitored using an analytically and clinically validated massively multiplex PCR-based dd-cfDNA assay to assess allograft injury and risk for rejection. Over the course of infection, low dd-cfDNA fractions were observed (below the 1% cutoff) and were accompanied by unusually highly elevated levels of total cfDNA, which gradually declined as the infection resolved. The case study highlights the variability in total cfDNA levels during and after viral infection, and the need to consider both total and dd-cfDNA levels when clinically interpreting the results for allograft rejection. Furthermore, the study highlights the importance of serial testing, wherein an interplay between total cfDNA and dd-cfDNA can inform the optimization of a patient’s immunosuppressive treatment regimen in response to infection. Lippincott Williams & Wilkins 2021-04-23 /pmc/articles/PMC8078311/ /pubmed/33912658 http://dx.doi.org/10.1097/TXD.0000000000001145 Text en Copyright © 2021 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Kidney Transplantation Bunnapradist, Suphamai Datta, Nakul Schaenman, Joanna Ioannou, Nick Bloom, Michelle S. Malhotra, Meenakshi Tabriziani, Hossein Gauthier, Philippe Ahmed, Ebad Billings, Paul R. Lum, Erik L. Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection |
title | Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection |
title_full | Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection |
title_fullStr | Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection |
title_full_unstemmed | Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection |
title_short | Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection |
title_sort | extremely high cell-free dna levels observed in renal allograft patient with sars-cov-2 infection |
topic | Kidney Transplantation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078311/ https://www.ncbi.nlm.nih.gov/pubmed/33912658 http://dx.doi.org/10.1097/TXD.0000000000001145 |
work_keys_str_mv | AT bunnapradistsuphamai extremelyhighcellfreednalevelsobservedinrenalallograftpatientwithsarscov2infection AT dattanakul extremelyhighcellfreednalevelsobservedinrenalallograftpatientwithsarscov2infection AT schaenmanjoanna extremelyhighcellfreednalevelsobservedinrenalallograftpatientwithsarscov2infection AT ioannounick extremelyhighcellfreednalevelsobservedinrenalallograftpatientwithsarscov2infection AT bloommichelles extremelyhighcellfreednalevelsobservedinrenalallograftpatientwithsarscov2infection AT malhotrameenakshi extremelyhighcellfreednalevelsobservedinrenalallograftpatientwithsarscov2infection AT tabrizianihossein extremelyhighcellfreednalevelsobservedinrenalallograftpatientwithsarscov2infection AT gauthierphilippe extremelyhighcellfreednalevelsobservedinrenalallograftpatientwithsarscov2infection AT ahmedebad extremelyhighcellfreednalevelsobservedinrenalallograftpatientwithsarscov2infection AT billingspaulr extremelyhighcellfreednalevelsobservedinrenalallograftpatientwithsarscov2infection AT lumerikl extremelyhighcellfreednalevelsobservedinrenalallograftpatientwithsarscov2infection |